AzTrials
AzTrials

SnoringNCT03372070

Continuous Negative External Pressure for the Treatment of Primary Snoring

A study testing cNEP in people with Snoring, run by Sommetrics, Inc. at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The aim of this pilot study is to gain information on the ability of a continuous negative external pressure collar to safely reduce snoring in primary snorers, and if so to determine whether the reduction in snoring has benefits for both the snorer and the bed partner. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Snoring
What is being tested?
cNEP
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Jan 2021to Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Key Snorer Inclusion Criteria:

  • BMI <35
  • if a previously done polysomnogram (PSG) is available, AHI<5
  • snoring identified by a previous PSG and/or by the bed partner

Key bed partner Inclusion criteria

  • must have regularly slept with the snorer over the previous month and must plan to sleep with the snorer for the duration of the trial
  • considers that the snorer's snoring is a problem
  • must discontinue use of any snore-masking equipment or ear plug for at least two weeks prior to the initial visit to the study site and agree to refrain from their use for the duration of the trial

Key snorer exclusion criteria:

  • sleep disturbance other than snoring
  • snoring due primarily to abnormality of the nasopharynx
  • use of snoring treatment during the month prior to the initial visit
  • neck anatomic or skin abnormalities
  • serious medical condition
  • excessive drug or alcohol intake

Key bed partner exclusion criteria:

-known sleep disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cleveland Clinic

    Cleveland, Ohio, 44195

Other trials in United States

About this study

Official title: Continuous Negative External Pressure (cNEP) for the Treatment of Primary Snoring: A Pilot Study

The aim of this pilot study is to gain information on the ability of a continuous negative external pressure collar to safely reduce snoring in primary snorers, and if so to determine whether the reduction in snoring has benefits for both the snorer and the bed partner. This clinical trial will involve both the snorer and his or her bed partner, both of whom must qualify and provide informed consent for participation.

Conditions
Snoring
Being tested
cNEP
Keywords
primary snoring, bed partner, home sleep testing
Medical subject headings
Snoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cNEPDevice

    Also called continuous negative external pressure

    soft silicon collar applied to anterior neck with negative pressure

Study groups in NCT03372070
Study groupRoleWhat they receive
cNEPExperimentalsilicone collar applied to anterior neck
Receives: Device: cNEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in snoring duration

    duration of snoring as a percent of total sleep time compared to baseline

    Measured: two weeks after initiation of treatment

Secondary outcomes (11)
  1. change in apnea-hypopnea index (AHI)

    mean AHI compared to baseline

    Measured: two weeks after initiation of treatment

  2. change in snoring intensity

    mean dBC compared to baseline

    Measured: two weeks after initiation of treatment

  3. Treatment-emergent adverse events

    tabulation of all adverse events during the clinical trial

    Measured: two weeks

  4. change in Epworth Sleepiness Scale (ESS)

    mean ESS compared to baseline (total range 0-24; lower score means less sleepy)

    Measured: two weeks after initiation of treatment

  5. Short Form Survey 36 (SF-36)

    mean SF-36 compared to baseline

    Measured: one week time frame, administered two weeks after initiation of treatment

  6. Clinical Global Impression (CGI) Scale: Snorer's sleep

    CGI "usual sleep score" vs baseline (score range "very much better to very much worse"

    Measured: previous week, assessed one and two weeks after initiation of treatment

  7. Clinical Global Impression (CGI) Scale: Bed partner's complaints about snoring

    CGI "bed partner complaints about your snoring" scale vs baseline (score range "complained very much less, to "complained very much more"

    Measured: previous week, assessed one and two weeks after initiation of treatment

  8. Clinical Global Impression (CGI) Scale: Acceptability of cNEP

    CGI "bed partner complaints about your snoring" scale vs baseline (score range "complained very much less, to "complained very much more"

    Measured: "overall experience to date", assessed one and two weeks after initiation of treatment

  9. Clinical Global Impression (CGI) Scale: Bed partner's impression of snorer's sleep

    CGI scale comparing snorer's sleep to baseline (score range "very much better to very much worse"

    Measured: previous week, assessed one and two weeks after initiation of treatment

  10. Clinical Global Impression (CGI) Scales: bed partner's sleep

    CGI scale comparing bed partner's sleep to baseline (score range "very much better to very much worse"

    Measured: previous week, assessed one and two weeks after initiation of treatment

  11. Clinical Global Impression (CGI) Scale: Bed partner's overall relationship with snorer

    CGI scale comparing bed partner's overall relationship wtih snorer to baseline (score range "very much better to very much worse"

    Measured: previous week, assessed one and two weeks after initiation of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2017
  2. Study startJan 2021 (estimated)
  3. Primary completionJan 2022 (estimated)
  4. Study completionJan 2023 (estimated)

Why it stopped: Administrative reasons

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03372070
Sponsor's protocol ID
SOM-026
Status last verified
Sep 2019
First submitted
8 Dec 2017
Last updated
2 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing cNEP in people with Snoring, run by Sommetrics, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 2 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in snoring duration (time frame: two weeks after initiation of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in